Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD)

Clinical trial NCT00683592 · COMPLETED

Trial details

NCT number: NCT00683592
Sponsor: Forest Laboratories
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2008-03-01
Primary completion: 2009-02-01
Enrollment: 481

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.